Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
GlobalRPh RX List - XYZAL
Product / population
XYZAL oral levocetirizine; numeric adjustment applies only from age 12.
Renal method
CrCl, mL/min; ambiguous shared endpoints at 30 and 50 in printed bands.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-07
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Printed CrCl bands overlap at 30 and 50
The RX renal bands share their 30 and 50 mL/min endpoints. Two printed ranges therefore touch the same exact boundary.
What to reconcile: Do not let software choose an interval at an ambiguous endpoint. Reconcile the exact product label and local policy; retain the pediatric and dialysis restrictions.
GlobalRPh-hosted RX List · XYZAL oral levocetirizine; numeric adjustment applies only from age 12.
Renal method: CrCl, mL/min; ambiguous shared endpoints at 30 and 50 in printed bands. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-07
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
For adults and patients >=12 years, the printed CrCl bands recommend: 50-80 mL/min, 2.5 mg once daily; 30-50, 2.5 mg every other day; 10-30, 2.5 mg twice weekly, every 3-4 days. The printed boundaries overlap at exactly 50 and 30; resolve these with the current label/local protocol rather than silently choosing a band. Do not use with CrCl <10 or hemodialysis. Children 6 months through 11 years with impaired renal function are contraindicated. These oral levocetirizine instructions are not the IV cetirizine QUZYTTIR regimen.
RDM35-rxlist-levocetirizine-76c45e1b42-C1 · Source locator: Renal impairment; dosage; warnings; pharmacokinetics, as identified in the selected retrieval.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.